Bridgeway Capital Management’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$95.6K Buy
208,925
+154,425
+283% +$142K ﹤0.01% 1125
2025
Q4
$120K Buy
54,500
+9,000
+20% +$14.5K ﹤0.01% 1108
2025
Q3
$72.3K Hold
45,500
﹤0.01% 1139
2025
Q2
$73.7K Sell
45,500
-20,000
-31% -$32.3K ﹤0.01% 1104
2025
Q1
$77.9K Sell
65,500
-71,500
-52% -$114K ﹤0.01% 1080
2024
Q4
$282K Hold
137,000
0.01% 937
2024
Q3
$347K Buy
+137,000
New +$447K 0.01% 945

Other funds holding GUTS

Bridgeway Capital Management's GUTS Position: Q1 2026 in Review

Bridgeway Capital Management increased its Fractyl Health (GUTS) stake by 283% in Q1 2026, buying an estimated $142K and bringing the position to 208,925 shares worth $95.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1125.

Bridgeway Capital Management first reported a position in GUTS in Q3 2024 and has held it in 7 quarters since. The position peaked at $347K in Q3 2024. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • Bridgeway Capital Management held 208,925 shares of Fractyl Health worth $95.6K as of Q1 2026.
  • Bridgeway Capital Management bought 154,425 Fractyl Health shares in Q1 2026, an estimated $142K.
  • Fractyl Health made up ﹤0.01% of Bridgeway Capital Management's portfolio in Q1 2026, its #1125 holding.
  • Bridgeway Capital Management first reported a position in Fractyl Health in Q3 2024 and has held it in 7 quarters since.
  • Bridgeway Capital Management's Fractyl Health position peaked at $347K in Q3 2024.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.